Free database of papers and journals






Results 1 to 20 of 753 articles found
1994

BIOAVAILABILITY OF HYDROXYCHLOROQUINE TABLETS IN PATIENTS WITH RHEUMATOID ARTHRITIS

Rheumatology (1.4 172), 33, 235-239.
2019

O39 Implementing screening for hydroxychloroquine ocular toxicity: how big is the problem? Epidemiology of hydroxychloroquine prescriptions in the UK Clinical Practice Research Datalink

Rheumatology (1.4 172), 58, .
1989

Intractable RA—Treatment with Combined Methotrexate, Azathioprine and Hydroxychloroquine

Rheumatology (1.4 172), 28, 271-272.
1997

Ophthalmological monitoring for hydroxychloroquine toxicity: a scientific review of available data.

Rheumatology (1.4 172), 36, 599-601.
1997

Should patients on hydroxychloroquine have their eyes examined regularly?

Rheumatology (1.4 172), 36, 514-515.
1990

RADIOLOGICAL PROGRESSION IN RHEUMATIOD ARTHRITIS: DO D-PENICILLAMINE AND HYDROXYCHLOROQUINE HAVE DIFFERENT EFFECTS?

Rheumatology (1.4 172), 29, 126-127.
2017

E63. HYDROXYCHLOROQUINE PRESCRIBING AND MONITORING PRACTICES AMONG RHEUMATOLOGISTS AND DERMATOLOGISTS IN IRELAND

Rheumatology (1.4 172), 56, .
1989

COMBINATION THERAPY WITH GOLD AND HYDROXYCHLOROQUINE IN RHEUMATOID ARTHRITIS: A PROSPECTIVE, RANDOMIZED, PLACEBO-CONTROLLED STUDY

Rheumatology (1.4 172), 28, 128-133.
2018

e59 Long-term hydroxychloroquine use: are lupus patients under-monitored? A university teaching hospital experience

Rheumatology (1.4 172), 57, .
2019

E018 National survey to evaluate current practice of initiating and monitoring hydroxychloroquine in secondary care

Rheumatology (1.4 172), 58, .
2017

E24. HYDROXYCHLOROQUINE RETINOPATHY: HOW SHOULD THIS RISK BE MONITORED?

Rheumatology (1.4 172), 56, .
2017

037. HYDROXYCHLOROQUINE-INDUCED RETINAL TOXICITY

Rheumatology (1.4 172), 56, .
2007

Hypoglycaemia induced by hydroxychloroquine in a non-diabetic patient treated for RA

Rheumatology (1.4 172), 47, 378-379.
1987

THE PRESCRIBING OF CHLOROQUINE AND HYDROXYCHLOROQUINE BY CONSULTANT RHEUMATOLOGISTS IN THE UK

Rheumatology (1.4 172), 26, 375-378.
1998

A long-term five-year randomized controlled trial of hydroxychloroquine, sodium aurothiomalate, auranofin and penicillamine in the treatment of patients with rheumatoid arthritis

Rheumatology (1.4 172), 37, 992-1002.
2017

SJÖGREN’S SYNDROME AND OTHER CONNECTIVE TISSUE DISORDERS308. HYDROXYCHLOROQUINE-INDUCED RETINOPATHY: TIME TO OPEN OUR EYES TO SCREENING?

Rheumatology (1.4 172), 56, .
2019

083 New retinal screening guidelines for hydroxychloroquine: feasibility and outcomes

Rheumatology (1.4 172), 58, .
2017

SYSTEMIC LUPUS ERYTHEMATOSUS AND ANTI-PHOSPHOLIPID SYNDROMEE60. NEW OPHTHALMIC MONITORING OF HYDROXYCHLOROQUINE: WILL THIS LEAD TO MORE PATIENTS HAVING THEIR TREATMENT STOPPED?

Rheumatology (1.4 172), 56, .
2021

Fetal safety of chloroquine and hydroxychloroquine use during pregnancy: a nationwide cohort study

Rheumatology (1.4 172), 60, 2317-2326.
2018

O06 Hydroxychloroquine use, risk of retinal toxicity, and potential impact of screening in a large tertiary centre

Rheumatology (1.4 172), 57, .
Anatomy of Results
The left numbers are the publication year, and the number of citations (hyperlink to the full citation report of the paper)
paranthesis after the journal provides its impact factor.
paranthesis after the author indicates the number of publications and Author's Impact Factor
EXALY
Authors
Journals
Institutions